NCT02858037View on ClinicalTrials.gov

Trial to Assess the Continued Safety of and Adherence to a Vaginal Ring Containing Dapivirine in Women

PHASE3CompletedINTERVENTIONAL
Enrollment

1,456

Participants

Timeline

Start Date

July 18, 2016

Primary Completion Date

October 10, 2018

Study Completion Date

October 10, 2018

Conditions
Human Immunodeficiency Virus
Interventions
COMBINATION_PRODUCT

Dapivirine Vaginal Ring

Dapivirine Vaginal Ring, 25 ring given monthly for at least one year.

Trial Locations (17)

3630

Medical Research Council of South Africa, Westville

4001

eThekwini Clinical Research Center, Durban

4340

Verulam Clinical Research Center, Durban

7750

Emavundleni Research Centre, Cape Town

Unknown

Johns Hopkins University Research Project, Blantyre

Malawi Clinical Research Center, Lilongwe

WRHI Clinical Research Center, Johannesburg

Botha's Hill Clinical Research Center, Durban

Chatsworth Clinical Research Center, Durban

Isipingo Clinical Research Center, Durban

Tongaat Clinical Research Center, Durban

Wits Reproductive Health and HIV Institute Research Centre, Johannesburg

Makerere University - Johns Hopkins University Research Collaboration Clinical Research Center, Kampala

MU-JHU Research Collaboration, Kampala

Seke South Clinical Research Center, Harare

Spilhaus Clinical Research Center, Harare

Zengeza Clinical Research Center, Harare

All Listed Sponsors
lead

International Partnership for Microbicides, Inc.

INDUSTRY

NCT02858037 - Trial to Assess the Continued Safety of and Adherence to a Vaginal Ring Containing Dapivirine in Women | Biotech Hunter | Biotech Hunter